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Given a lack of evidence to accurately determine the risks and benefits of 
genetically modified foods (GMOs), an intense debate continues between 
its promoters and opponents.
Some authors highlight the advantages of consuming GMOs, for exam-
ple, their ability to address certain needs such as hunger. They also believe 
non-GMOs have not been sufficiently studied, some of which have been 
documented as allergenic or carcinogenic under certain conditions.
On the other hand, those who question consuming GMOs believe that 
their effects on health have not been sufficiently studied, that they may be 
allergenic and could produce antibiotic resistance and probable carcinoge-
nic effects. Nevertheless, most of these statements are based on in vitro or 
animal experiments, the latter generally corresponding to short time pe-
riods for which long-term effects cannot be detected (1). Given the type 
of evidence available, various uncertainties exist when extrapolating the 
results to the human population.
Scientific evidence based on epidemiological studies is therefore neces-
sary (2,3), but this requires addressing certain difficulties such as having 
databases that identify the properties of the product and obtaining data that 
indicate whether persons who have consumed GMOs have had any health 
problems. It is also necessary to evaluate the effects and determine how they 
will be evaluated and how exposure will be measured. Another difficulty 
is identifying comparable populations with other types of consumption (4).
Lacking more evidence about these products, especially epidemiological, 
it is difficult to understand the emphasis on their consumption not being as-
sociated with any risks. What is clear is that “the study has begun” with large 
groups of populations that have already begun to consume these foods. 
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